Entero Therapeutics receives Nasdaq notification regarding delayed form 10-Q Source: Seekingalpha
Author: Helitra.com
Gilnature/iStock by way of Getty Images Pharmaceutical firm ARCA biopharma (NASDAQ:ABIO) stated on Friday its board has permitted a reverse stock split of its shares at…
Trials for psychedelic drug candidate for PTSD under scrutiny by FDA – report Source: Seekingalpha
JP Yim The head of the World Health Organization (WHO) has mentioned that a world response plan to fight the continuing mpox outbreak would require roughly…
Roman Didkivskyi Siemens Healthineers (OTCPK:SEMHF) is wanting to pay greater than €200M ($224M) to purchase a Novartis (NYSE:NVS) business centered on producing radioactive chemical compounds for…
travellinglight/iStock by way of Getty Images Shortly after a U.Ok. watchdog declined to endorse Biogen’s (NASDAQ:BIIB) Alzheimer’s drug Leqembi to be used within the nation’s nationwide…
U.Ozel.Images/E+ by way of Getty Images Although different firms are poised to have GLP-1 receptor agonist medicine for weight loss authorized, they don’t seem to be…
ImmunoPrecise Antibodies (NASDAQ:IPA) acquired a written notification from Nasdaq, notifying them that they don’t adjust to the minimal bid worth requirement outlined within the Nasdaq Listing…
Chinese medical device supplier WORK Medical prices U.S. IPO Source: Seekingalpha
Altamira Therapeutics extends distribution agreement with Pharma Nordic Source: Seekingalpha